2'-Deoxyuridine

CAT:
804-HY-D0186-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
2'-Deoxyuridine - image 1

2'-Deoxyuridine

  • UNSPSC Description:

    2’-deoxyuridine is a brain-penetrant pyrimidines nucleotide that is associated with nervous system diseases. 2'-Deoxyuridine could increase chromosome breakage and results in a decreased thymidylate synthetase activity. 2'-Deoxyuridine is a precursor in the synthesis of Edoxudine (HY-B1011) and also an analogue of 5-ethynyl-2'-deoxyuridine, EdU (HY-118411). 2’-deoxyuridine reduces microglial activation and improve oxidative stress damage by modulating glycolytic metabolism on the Aβ25-35-induced brain injury, which is promising for research of Alzheimer’s disease (AD)[1][2][3].
  • Target Antigen:

    Endogenous Metabolite; Thymidylate Synthase
  • Type:

    Natural Products
  • Related Pathways:

    Apoptosis;Metabolic Enzyme/Protease
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Infection
  • Assay Protocol:

    https://www.medchemexpress.com/2_acute_-Deoxyuridine.html
  • Purity:

    99.98
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)|H2O : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C(N1)N([C@H]2C[C@H](O)[C@@H](CO)O2)C=CC1=O
  • Molecular Weight:

    228.204
  • References & Citations:

    [1]Reidy JA, et al. Deoxyuridine increases folate-sensitive fragile site expression in human lymphocytes. Am J Med Genet. 1987 Jan;26(1):1-5.|[2]Ashraf Saad Rasheed, et al. Development of ZIC-HILIC methods using ultraviolet detection for determining 2-deoxyuridine in human serum[J]. Systematic Reviews in Pharmacy. 2020 March; 11(2):388-394.|[3]Liu M, et al. Thymidine and 2'-deoxyuridine reduce microglial activation and improve oxidative stress damage by modulating glycolytic metabolism on the Aβ25-35-induced brain injury[J]. Arch Biochem Biophys. 2022 Oct 30;729:109377.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    951-78-0